| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |